Amid market volatility, Chevron Corporation (CVX) is drawing investor attention for its resilient cash generation and a 38-year record of dividend growth. Analysts highlight its integrated model and strategic assets as buffers against commodity price swings, positioning it as a cornerstone for income-focused portfolios.
While Winter Storm Devin triggered JetBlue's late-December collapse, a closer look reveals a fragile operational system, concentrated network, and strained labor relations that pose significant ongoing risks for the airline and its investors.
With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
Cisco Systems' stock is gaining momentum, fueled by surging demand from hyperscalers building AI data centers. The networking giant's raised guidance and record revenue have triggered a wave of analyst upgrades, positioning it as a key beneficiary of the AI infrastructure build-out.
A deep dive into the mounting challenges facing Unity Software Inc., from eroding developer trust and fierce competition to financial pressures, as a prominent bear thesis gains traction among investors.
The autonomous vehicle leader Waymo has closed a massive $16 billion funding round, catapulting its valuation to $126 billion. The capital infusion is set to turbocharge its international expansion plans, even as it navigates operational challenges and intensifying competition from rivals like Tesla and Amazon's Zoox.
After a sharp post-earnings sell-off and insider sales, Power Solutions International (PSIX) faces a critical test. Investors are weighing near-term execution risks against the company's strategic positioning in the surging demand for data center power generation.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
ServiceNow stock rose nearly 1% on Monday, outperforming the broader market, after Goldman Sachs added the workflow software giant to its prestigious Conviction List, citing significant expansion potential into new enterprise software segments.
Despite a recent rally, analysts argue Dollar General's defensive business model, deep rural footprint, and focus on essentials position it for steady, long-term growth as a haven for value-conscious investors.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
Amid a challenging retail landscape, Target Corporation (TGT) is drawing attention from value investors who argue its depressed stock price and reliable dividend profile present a compelling opportunity for steady returns.
Investment firm Kiker Wealth Management has significantly reduced its holdings in the Invesco PDBC ETF, part of a sweeping divestment that slashed its total assets from $198 million to just $3 million by year-end 2025.
The release of millions of pages from the Jeffrey Epstein case by the U.S. Justice Department has unveiled the late financier's social and professional ties to a vast array of powerful figures across politics, finance, and tech, raising fresh questions about the scope of his influence.
Despite Adtalem Global Education posting robust quarterly results with 34% EPS growth, investment firm Peregrine Asset Advisers has liquidated its entire position, raising questions about the divergence between corporate performance and investor sentiment in the education sector.
Walmart stock jumped over 4% Monday as a new trade agreement between the U.S. and India promises lower tariffs and increased market access, bolstering the retail giant's strategic pivot toward Indian manufacturing and e-commerce.
Often overshadowed by flashier tech names, glass and materials science giant Corning has secured a multi-year, $6 billion agreement with Meta Platforms to supply optical fiber for AI data centers, positioning itself as a critical but under-the-radar beneficiary of the infrastructure build-out.
Once a high-flying adtech darling, The Trade Desk has seen its stock crater nearly 80% from its peak amid a fierce battle with Amazon's ad juggernaut. With shares now trading at a significant discount to the market, analysts are divided on whether this marks a historic buying opportunity or signals deeper structural challenges.
